NIH 2003
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
$681,170 |
NIH 2003
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Agencourt Bioscience Corporation |
$313,227 |
NIH 2002
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
$3,307,953 |
NIH 2001
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
$7,335,882 |
NIH 2001
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
$71,254 |
NIH 2000
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
$1,716,665 |
NIH 1999
U54 HG |
Gtc Sequencing Center
Smith, Douglas R. / Oscient Pharmaceuticals Corporation |
|
